Syngene International Limited Overview
Pro stress-test →Syngene International is India's leading integrated drug discovery, development and manufacturing services (DDMS) provider. The company offers preclinical and clinical services to global pharmaceutical and biotech clients, positioning itself as a critical bridge between innovation and commercialization in the global life sciences ecosystem.
Strategic Profile
Pro stress-test →Syngene competes on a platform model combining scientific expertise, regulatory capabilities, and manufacturing infrastructure for global pharma and biotech clients. Its competitive advantage lies in cost-effective execution, scientific quality, and established relationships with major pharmaceutical partners globally.
Competitive Landscape
Pro stress-test →Syngene competes with global CDMOs like Lonza, Catalent, and Fareva, as well as Indian peers including Dr. Reddy's Labs and other CRO/CDMO providers. Differentiation comes through cost efficiency, scientific credibility, and dedicated focus on discovery and development services.
Industry Context
Syngene International Limited operates in Contract Research and Manufacturing Services (CDMO/DDMS).
Key facts
Founded: 1993 · Headquarters: Bangalore, India · Employees: 3,500 · Revenue: $450M · Market cap: $2.8B